XML 86 R72.htm IDEA: XBRL DOCUMENT v3.25.4
Shareholders’ Equity - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 30, 2025
Sep. 26, 2024
Jul. 31, 2025
Jan. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Aug. 12, 2024
Oct. 25, 2023
Subsidiary, Sale of Stock [Line Items]                  
Shares unsettled (in shares)         8,840,000        
Issuance of common stock in public offerings, net         $ 188,341,000 $ 135,475,000 $ 271,389,000    
Payment of OP unit distributions         $ (358,000) $ (369,000) $ (407,000)    
OP Unit Conversion Ratio         1 1      
Common stock                  
Subsidiary, Sale of Stock [Line Items]                  
Units converted (in shares)         12,813 54,342 34,169    
Netstreit, L.P. (The Operating Partnership)                  
Subsidiary, Sale of Stock [Line Items]                  
Non-controlling interest holders ownership         0.40% 0.50%      
Restricted Stock Units (RSUs)                  
Subsidiary, Sale of Stock [Line Items]                  
Forfeited during period (in shares)         50,000 90,000 37,000    
Forfeited during period         $ 800,000 $ 1,500,000 $ 700,000    
July 2025 Follow-On Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Maximum Sales Authorization (in shares)     12,420,000            
Shares unsettled (in shares) 4,264,947                
Weighted-average price (in dollars per share) $ 16.81   $ 17.70            
Number of shares sold (in shares) 8,155,053                
Issuance of common stock in public offerings, net $ 137,000,000                
Payment of deferred offering costs $ 7,600,000                
Public Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Maximum Sales Authorization (in shares)     12,420,000 11,040,000          
Shares unsettled (in shares)     4,264,947 8,840,000          
August 2022 Follow-On Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Weighted-average price (in dollars per share)       $ 18.00          
Common stock                  
Subsidiary, Sale of Stock [Line Items]                  
Weighted-average price (in dollars per share)         $ 16.47 $ 16.50 $ 17.22    
Number of shares sold (in shares)         3,185,262 5,983,711 7,662,341    
Issuance of common stock in public offerings, net         $ 51,562,000 $ 97,661,000 $ 130,274,000    
Payment of deferred offering costs         884,000 $ 1,070,000 $ 1,638,000    
Common stock | 2023 ATM Program                  
Subsidiary, Sale of Stock [Line Items]                  
Maximum Sales Authorization         $ 300,000,000       $ 300,000,000.0
Shares unsettled (in shares)         1,743,100        
Weighted-average price (in dollars per share)         $ 17.67        
Issuance of common stock in public offerings, net         $ 30,806,000        
Common stock | 2024 ATM Program                  
Subsidiary, Sale of Stock [Line Items]                  
Maximum Sales Authorization         $ 300,000,000     $ 300.0  
Shares unsettled (in shares)         6,770,787 152,547      
Weighted-average price (in dollars per share)           $ 17.13      
Issuance of common stock in public offerings, net         $ 123,229,000        
Common stock | 2024 ATM Program, 2025 Activity                  
Subsidiary, Sale of Stock [Line Items]                  
Weighted-average price (in dollars per share)         $ 17.75        
Common stock | 2024 ATM Program, 2025 Activity | Maximum                  
Subsidiary, Sale of Stock [Line Items]                  
Shares unsettled (in shares)         9,068,486        
Common stock | Public Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Weighted-average price (in dollars per share)   $ 17.22              
Number of shares sold (in shares)   2,200,000 8,155,053 2,200,000          
Issuance of common stock in public offerings, net   $ 37,800,000              
Payment of deferred offering costs   $ 1,800,000